Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy

[1] Sauer R(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740

[2] Becker H(2009)Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancer Anticancer Drugs 20 519-524

[3] Hohenberger W(2009)Molecular targeted treatment and radiation therapy for rectal cancer Strahlenther Onkol 185 371-378

[4] Rodel C(1990)What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 4-6

[5] Wittekind C(2006)Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy Oncology 71 312-319

[6] Fietkau R(2010)Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review Clin Ther 32 437-453

[7] Martus P(2006)Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases Br J Cancer 94 1710-1717

[8] Tschmelitsch J(2008)Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy Br J Cancer 98 450-456

[9] Hager E(2000)Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa Int J Cancer 86 174-181

[10] Hess CF(2010)Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer Oncology 78 369-375

[1] Sauer R(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740

[2] Becker H(2009)Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancer Anticancer Drugs 20 519-524

[3] Hohenberger W(2009)Molecular targeted treatment and radiation therapy for rectal cancer Strahlenther Onkol 185 371-378

[4] Rodel C(1990)What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 4-6

[5] Wittekind C(2006)Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy Oncology 71 312-319

[6] Fietkau R(2010)Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review Clin Ther 32 437-453

[7] Martus P(2006)Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases Br J Cancer 94 1710-1717

[8] Tschmelitsch J(2008)Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy Br J Cancer 98 450-456

[9] Hager E(2000)Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa Int J Cancer 86 174-181

[10] Hess CF(2010)Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer Oncology 78 369-375